31Indexed trials
mesh condition
Diabetes Mellitus
Intelligence
Diabetes Mellitus intelligence: 31 indexed trials, 6 recruiting studies, 29 sponsors across 20 countries.
6Recruiting
29Sponsors
20Countries
Leading sponsors
GlaxoSmithKline20 recruiting
Columbia University21 recruiting
Cambridge University Hospitals NHS Foundation Trust11 recruiting
Daiichi Sankyo10 recruiting
Federal University of Rio Grande do Sul10 recruiting
Forschungsinstitut der Diabetes Akademie Mergentheim10 recruiting
International Rescue Committee10 recruiting
Binghamton University10 recruiting
Joslin Diabetes Center10 recruiting
King's College London10 recruiting
Laval University11 recruiting
Abliva AB11 recruiting
Geographic activity
United States11trials
United Kingdom5trials
Canada4trials
Germany3trials
Netherlands2trials
Indonesia1trials
Italy1trials
Belgium1trials
Russia1trials
Singapore1trials
South Korea1trials
Spain1trials
Leading interventions
Gabapentin prescriptions2trials
Approach A (PeeSpot urine collection device).1trials
Conventional Physical therapy1trials
Cognitive restructuring of diabetes-related problems1trials
Collaborative depression care management1trials
Common Elements Treatment Approach1trials
Approach B (ACR | EU Test kit).1trials
DS-1971a1trials
Diabetes complications1trials
Diabetes-related affective problems analysis1trials
Diabetes-specific problem-solving therapy1trials
Activation of personal and social resources1trials
Methodology note
This entity is derived from structured ClinicalTrials.gov conditions and/or MeSH normalization. Counts reflect the current NeuroRisk indexed corpus and are not guaranteed exhaustive global totals.